TABLE 1.

Select clinical, demographic, and treatment variables of women diagnosed with endometrial cancer from a single institution by race

Variable	White (n = 356)		Black (n = 271)		P valuea
	n	%	n	%
Age at diagnosis, y					.204
<50	49	14	32	12
50–59	71	20	39	14
60–69	112	31	99	37
70+	124	35	101	37
International Federation of Gynecologists and Obstetricians stage					< .001
I	246	69	142	52
II	40	11	32	12
III	40	11	37	14
IV	19	5	45	17
Unknown	11	3	15	6
Grade					< .001
I	189	53	79	29
II	67	19	35	13
III	91	26	135	50
Unknown	9	3	22	8
Histologic group					< .001
Type I	260	73	148	55
Type II	67	19	84	31
Type III	24	7	33	12
Other	5	1	6	2
Modified Charlson comorbidity score					.305
None	208	58	140	52
1	64	18	55	20
≥2	84	24	73	27
Unknown	0	0	3	1
Hypertension					< .001
No	151	42	65	24
Yes	205	58	206	76
Diabetes mellitus					.086
No	275	77	193	71
Yes	81	23	78	29
Body mass index, kg/m2					< .001
<25	66	19	31	11
25–29.9	91	26	38	14
30–39.9	108	30	119	44
≥40	76	21	74	27
Unknown	15	4	9	3
Smoking history					.590
Nonsmoker	223	63	182	67
Current	47	13	30	11
Former	75	21	55	20
Unknown	11	3	4	1
Nulliparity					.004
No	264	74	218	80
Yes	85	24	38	14
Unknown	7	2	15	6
Parity					< .001
None	85	24	38	14
1–3	186	52	126	46
≥4	77	22	92	34
Unknown	8	2	15	6
Surgery					< .001
No	14	4	45	17
Yes	342	96	226	83
Radiation therapy					.686
No	225	63	167	62
Yes	131	37	104	38
Chemotherapy					.041
No	286	80	199	73
Yes	70	20	72	27
Vital Status					< .001
Alive	164	46	100	37
Deceased
Endometrial cancer	43	12	66	24
Other reason	149	42	105	39

^aCalculation does not include unknown values.

Ruterbusch. Race, comorbidities, and endometrial cancer survival. Am J Obstet Gynecol 2014.